Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial

被引:0
作者
Valerie A. Sera
Ann E. Stevens
Howard K. Song
Victor M. Rodriguez
Frederick A. Tibayan
Miriam M. Treggiari
机构
[1] Oregon Health & Science University,Department of Anesthesiology and Perioperative Medicine
[2] Kaiser Permanente,Department of Anesthesiology
[3] Oregon Health & Science University,Department of Cardiothoracic Surgery
[4] UC Davis Vascular Center,Department of Surgery, Division of Cardiothoracic Surgery
[5] Yale University,Department of Anesthesiology
来源
Pilot and Feasibility Studies | / 7卷
关键词
Adult anesthesia; Anesthetics; Cardiac surgery; Bleeding disorders; Coagulopathies; Hematology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 82 条
[1]  
Engoren MC(2002)Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 74 1180-1186
[2]  
Habib RH(2006)Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting Crit Care Med 34 1608-1616
[3]  
Zacharias A(2006)Transfusion in coronary artery bypass grafting is associated with reduced long-term survival Ann Thorac Surg 81 1650-1657
[4]  
Schwann TA(2005)Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery Eur J Cardiothorac Surg 27 592-598
[5]  
Riordan CJ(2007)Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery Circulation 116 2544-2552
[6]  
Durham SJ(2008)Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery Ann Card Anaesth 11 15-19
[7]  
Koch CG(2006)Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure Circulation 114 I-43-I-48
[8]  
Li L(2005)Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study Br J Anaesth 95 596-602
[9]  
Duncan AI(2004)FEIBA: mode of action Haemophilia 10 3-9
[10]  
Mihaljevic T(2014)Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life in haemophilia patients with inhibitors: results from FEIBA NF Prophylaxis Study Haemophilia 20 644-650